)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Ginkgo Bioworks (DNA) investor relations material
Ginkgo Bioworks Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary6 Nov, 2025
Executive summary
Focused on expanding autonomous lab robotics, AI-driven tools, and software for bioscience customers, with strategic partnerships extended, including Bayer and BARDA, and a shift toward a tools business model.
Revenue declined significantly year-over-year, mainly due to lower non-cash revenue from contract terminations and reduced activity in both Cell Engineering and Biosecurity segments.
Restructuring actions, including workforce reductions and facility consolidations, were largely completed, driving cost reductions and improved operational efficiency.
Maintained a strong liquidity position with $462 million in cash, cash equivalents, and marketable securities as of September 30, 2025, and no bank debt.
Strategic partnerships and government contracts, such as the $22 million BARDA award and Bayer extension, support growth in AI-driven bioscience and automation.
Financial highlights
Q3 2025 total revenue was $39 million, down 56% year-over-year, mainly due to a prior year non-cash deferred revenue release; Cell Engineering revenue was $29 million, Biosecurity revenue was $9–10 million.
Net loss (GAAP) for Q3 2025 was $81 million, compared to $56 million in Q3 2024; adjusted EBITDA for Q3 2025 was $(56) million, compared to $(20) million in Q3 2024.
Cash burn in Q3 2025 was $28 million, a significant reduction from prior periods.
Operating expenses for Q3 2025 were $129 million, down from $144 million in Q3 2024.
Cash used in operations for the first nine months of 2025 was $123 million, a substantial improvement from the prior year.
Outlook and guidance
Full-year 2025 total revenue guidance reaffirmed at $167–$187 million, with Cell Engineering expected at $117–$137 million and Biosecurity at least $40 million.
Management expects expenditures to exceed revenue over the next 12 months as investments continue in R&D, platform expansion, and restructuring.
Continued focus on cost reduction and cash burn improvements while investing in AI and automation for growth.
What drives confidence in full-year revenue outlook?
How do new partnerships leverage AI capabilities?
Path to Adjusted EBITDA breakeven
Achieve 80/20 tools/services revenue mix by 2030
What is the financial impact of Google Cloud reset?
How do RACs overcome traditional automation limits?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Ginkgo Bioworks earnings date
Q4 202524 Feb, 2026
Next Ginkgo Bioworks earnings date
Q4 202524 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Ginkgo Bioworks Holdings, Inc, a biomolecular engineering company, develops biological manufacturing technologies to program cells for molecular manufacturing systems. Ginkgo Bioworks Holdings software engineering platform uses the widely used programming language Python and its library of bioinformatics functions and statistical methods. Ginkgo Bioworks' programs are designed to modify bacterial genes to make organic compounds such as vanillin, scents to produce civetone in bacteria, Beta-carotene and lycopene in yeast cells, gluconic acid in E. coli; and shikimic acid and artemisinic acid in yeast cells. The company sells its products to pharmaceutical companies including AstraZeneca Group and Eli Lilly & Co; chemical companies including Firmenich SA; flavor, aroma, and fragrance companies; craft breweries; and others.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage